These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14567973)

  • 1. Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.
    Fleming JC; Tartaglini E; Kawatsuji R; Yao D; Fujiwara Y; Bednarski JJ; Fleming MD; Neufeld EJ
    Mol Genet Metab; 2003; 80(1-2):234-41. PubMed ID: 14567973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
    Oishi K; Hofmann S; Diaz GA; Brown T; Manwani D; Ng L; Young R; Vlassara H; Ioannou YA; Forrest D; Gelb BD
    Hum Mol Genet; 2002 Nov; 11(23):2951-60. PubMed ID: 12393806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
    Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
    Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
    Fleming JC; Tartaglini E; Steinkamp MP; Schorderet DF; Cohen N; Neufeld EJ
    Nat Genet; 1999 Jul; 22(3):305-8. PubMed ID: 10391222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
    Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
    Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
    Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
    Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.
    Jungtrakoon P; Shirakawa J; Buranasupkajorn P; Gupta MK; De Jesus DF; Pezzolesi MG; Panya A; Hastings T; Chanprasert C; Mendonca C; Kulkarni RN; Doria A
    Diabetes; 2019 May; 68(5):1084-1093. PubMed ID: 30833467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
    Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
    Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
    Gritli S; Omar S; Tartaglini E; Guannouni S; Fleming JC; Steinkamp MP; Berul CI; Hafsia R; Jilani SB; Belhani A; Hamdi M; Neufeld EJ
    Br J Haematol; 2001 May; 113(2):508-13. PubMed ID: 11380424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
    Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N
    Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
    Neufeld EJ; Fleming JC; Tartaglini E; Steinkamp MP
    Blood Cells Mol Dis; 2001; 27(1):135-8. PubMed ID: 11358373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
    Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
    BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
    Manimaran P; Subramanian VS; Karthi S; Gandhimathi K; Varalakshmi P; Ganesh R; Rathinavel A; Said HM; Ashokkumar B
    Clin Chim Acta; 2016 Jan; 452():44-9. PubMed ID: 26549656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
    Mozzillo E; Melis D; Falco M; Fattorusso V; Taurisano R; Flanagan SE; Ellard S; Franzese A
    Pediatr Diabetes; 2013 Aug; 14(5):384-7. PubMed ID: 23289844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family.
    Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
    Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
    Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
    Enogieru OJ; Koleske ML; Vora B; Ngo H; Yee SW; Chatad D; Sirota M; Giacomini KM
    AAPS J; 2021 Mar; 23(2):35. PubMed ID: 33649974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
    Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
    Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
    Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
    Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
    Lagarde WH; Underwood LE; Moats-Staats BM; Calikoglu AS
    Am J Med Genet A; 2004 Mar; 125A(3):299-305. PubMed ID: 14994241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.